Stage III Grade 3 Follicular Lymphoma Completed Phase Trials for Valganciclovir (DB01610)
Indication | Status | Phase |
---|---|---|
DBCOND0028630 (Stage III Grade 3 Follicular Lymphoma) | Completed | Not Available |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01199562 | Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant | Supportive Care |